Cyclopentanamine

Cyclopentanamine

SCHEMBL1443414

NC1CCCC1.O=C(O)C1CCN(c2nc3cc(Cl)c(Cl)cc3[nH]2)CC1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 1/20 0.46
▸ MAPT P10636 4/20 0.44
▸ EGLN1 Q9GZT9 3/20 0.44
▸ TRPC3 Q13507 1/20 0.43
▸ NOTUM Q6P988 2/20 0.43
▸ LMNA P02545 3/20 0.42
▸ NPY5R Q15761 1/20 0.42
▸ TP53 P04637 3/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439972 0.93 SLC6A9 (0.51) SLC6A9MAPTEGLN1TRPC3NOTUM
SCHEMBL1440776 0.84 MAPT (0.55) SLC6A9MAPTTRPC3LMNATP53
SCHEMBL1440170 0.84 MAPT (0.55) SLC6A9MAPTTRPC3LMNATP53
SCHEMBL1440054 0.81 PTGES (0.52) MAPTLMNATP53HPGDTSHR
SCHEMBL1440421 0.79 PTGES (0.52) MAPTLMNATP53TSHR
SCHEMBL1443417 0.78 TP53 (0.44) SLC6A9MAPTEGLN1TRPC3LMNA
SCHEMBL1439951 0.78 MAPT (0.52) MAPTEGLN1TRPC3LMNANPY5R
SCHEMBL1441243 0.78 MAPT (0.52) MAPTLMNATP53
SCHEMBL1440520 0.78 GAA (0.55) MAPTLMNATP53
SCHEMBL1440521 0.76 MAPT (0.55) MAPTLMNATP53NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011023812-A1 MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 (MPGES1) INHIBITORS NOVASAID AB (SE) 2011-03-03 — — WO disclosed
Send feedback